Form 8-K - Current report:
SEC Accession No. 0001564590-20-005048
Filing Date
2020-02-18
Accepted
2020-02-18 16:36:06
Documents
25
Period of Report
2020-02-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20200218.htm 8-K 37638
2 EX-99.1 abio-ex991_7.htm EX-99.1 107317
3 EX-99.2 abio-ex992_19.htm EX-99.2 25186
4 GRAPHIC gdighdpznlyt000011.jpg GRAPHIC 313529
5 GRAPHIC gdighdpznlyt000012.jpg GRAPHIC 352266
6 GRAPHIC gdighdpznlyt000018.jpg GRAPHIC 269467
7 GRAPHIC gdighdpznlyt000008.jpg GRAPHIC 244056
8 GRAPHIC gdighdpznlyt000013.jpg GRAPHIC 426555
9 GRAPHIC gdighdpznlyt000019.jpg GRAPHIC 329273
10 GRAPHIC gdighdpznlyt000020.jpg GRAPHIC 148776
11 GRAPHIC gdighdpznlyt000005.jpg GRAPHIC 365426
12 GRAPHIC gdighdpznlyt000004.jpg GRAPHIC 311516
13 GRAPHIC gdighdpznlyt000009.jpg GRAPHIC 251736
14 GRAPHIC gdighdpznlyt000007.jpg GRAPHIC 315983
15 GRAPHIC gdighdpznlyt000014.jpg GRAPHIC 422913
16 GRAPHIC gdighdpznlyt000016.jpg GRAPHIC 321222
17 GRAPHIC gdighdpznlyt000001.jpg GRAPHIC 476671
18 GRAPHIC gdighdpznlyt000017.jpg GRAPHIC 318527
19 GRAPHIC gdighdpznlyt000015.jpg GRAPHIC 279172
20 GRAPHIC gdighdpznlyt000002.jpg GRAPHIC 517877
21 GRAPHIC gdighdpznlyt000006.jpg GRAPHIC 253051
22 GRAPHIC gdighdpznlyt000003.jpg GRAPHIC 332137
23 GRAPHIC gdighdpznlyt000021.jpg GRAPHIC 466711
24 GRAPHIC gdighdpznlyt000010.jpg GRAPHIC 356674
25 GRAPHIC gvfmwwhps3wa000001.jpg GRAPHIC 20861
  Complete submission text file 0001564590-20-005048.txt   9943993
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 20625842
SIC: 2835 In Vitro & In Vivo Diagnostic Substances